Healthcare -
Biotechnology - NASDAQ - US
$ 243.34
-1.38 %
$ 31.5 B
Market Cap
-112.14
P/E
ALNY - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative ALNY - Alnylam Pharmaceuticals, Inc.
976 M
LAST VALUE
12.51%
2 YEAR CAGR
15.29%
5 YEAR CAGR
36.16%
10 YEAR CAGR